MX9302629A - Purificacion del inhibidor-activador de plasminogeno 2 por cromatografia de inmunoafinidad. - Google Patents

Purificacion del inhibidor-activador de plasminogeno 2 por cromatografia de inmunoafinidad.

Info

Publication number
MX9302629A
MX9302629A MX9302629A MX9302629A MX9302629A MX 9302629 A MX9302629 A MX 9302629A MX 9302629 A MX9302629 A MX 9302629A MX 9302629 A MX9302629 A MX 9302629A MX 9302629 A MX9302629 A MX 9302629A
Authority
MX
Mexico
Prior art keywords
activator
plasminogen
inhibitor
purification
immuno
Prior art date
Application number
MX9302629A
Other languages
English (en)
Inventor
Johann Hock
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of MX9302629A publication Critical patent/MX9302629A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00—Packet switching elements
    • H04L49/10—Packet switching elements characterised by the switching fabric construction
    • H04L49/102—Packet switching elements characterised by the switching fabric construction using shared medium, e.g. bus or ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8132—Plasminogen activator inhibitors
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00—Packet switching elements
    • H04L49/10—Packet switching elements characterised by the switching fabric construction
    • H04L49/103—Packet switching elements characterised by the switching fabric construction using a shared central buffer; using a shared memory
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04L—TRANSMISSION OF DIGITAL INFORMATION, e.g. TELEGRAPHIC COMMUNICATION
    • H04L49/00—Packet switching elements
    • H04L49/30—Peripheral units, e.g. input or output ports
    • H04L49/3027—Output queuing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Signal Processing (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Data Exchanges In Wide-Area Networks (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

El procedimiento se refiere a un procedimiento para la purificación por cromatografía de inmunoafinidad del inhibidor-activador de plasminogeno 2 (PAI-2), y a anticuerpos monoclonales que son apropiados para tal procedimiento.
MX9302629A 1992-05-06 1993-05-04 Purificacion del inhibidor-activador de plasminogeno 2 por cromatografia de inmunoafinidad. MX9302629A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4214999A DE4214999C2 (de) 1992-05-06 1992-05-06 Reinigung von Plasminogen-Aktivator-Inhibitor 2 durch Immunaffinitätschromatographie

Publications (1)

Publication Number Publication Date
MX9302629A true MX9302629A (es) 1993-11-01

Family

ID=6458317

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9302629A MX9302629A (es) 1992-05-06 1993-05-04 Purificacion del inhibidor-activador de plasminogeno 2 por cromatografia de inmunoafinidad.

Country Status (12)

Country Link
US (1) US5362857A (es)
EP (1) EP0568836A1 (es)
JP (1) JPH069695A (es)
KR (2) KR930024353A (es)
AU (1) AU3837193A (es)
CA (1) CA2095577A1 (es)
DE (1) DE4214999C2 (es)
IL (1) IL105610A0 (es)
MX (1) MX9302629A (es)
NO (1) NO931629L (es)
NZ (1) NZ247533A (es)
ZA (1) ZA932443B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999049887A1 (en) 1998-04-01 1999-10-07 Biotech Australia Pty. Limited Use of protease inhibitors for treating skin wounds
US7265248B1 (en) 2005-04-29 2007-09-04 Technology Innovations, Llc Compositions and methods for the treatment of malaria

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134065A (en) * 1986-05-16 1992-07-28 Monsanto Company Tissue plasminogen activator inhibitor and method of purification
DE3713272A1 (de) * 1987-04-18 1988-11-03 Behringwerke Ag Plasminogenaktivator-inhibitor, typ 2 (pai-2)
DE3929504A1 (de) * 1989-09-06 1991-03-07 Behringwerke Ag Verfahren zur reinigung von plasminogen-aktivator-inhibitor 2 (pai-2)
US5204256A (en) * 1989-09-06 1993-04-20 Behringwerke Aktiengesellschaft Process for the purification of plasminogen activator inhibitor 2 (pai-2)
ES2106772T3 (es) * 1989-12-20 1997-11-16 Biotech Australia Pty Ltd Variantes de pai-2.

Also Published As

Publication number Publication date
KR930024353A (ko) 1993-12-22
NO931629L (no) 1993-11-08
ZA932443B (en) 1993-10-20
DE4214999C2 (de) 1994-07-14
NZ247533A (en) 1994-12-22
NO931629D0 (no) 1993-05-05
JPH069695A (ja) 1994-01-18
CA2095577A1 (en) 1993-11-07
EP0568836A1 (de) 1993-11-10
US5362857A (en) 1994-11-08
IL105610A0 (en) 1993-09-22
AU3837193A (en) 1993-11-11
KR940005284A (ko) 1994-03-21
DE4214999A1 (de) 1993-11-11

Similar Documents

Publication Publication Date Title
ATE193839T1 (de) Reinigung von proteinen
YU47525B (sh) Zeleno staklo za apsorpciju infracrvenog i ultravioletnog zračenja i automobilsko staklo izradjeno od istog
GR920100471A (el) Κα?αρισμένη ανοσογλοβουλίνη.
ES8305761A1 (es) Un procediemiento para la preparacion de lactamas biciclicas.
DE3586536T2 (de) Monoklonaler antikoerper gegen ein cytotoxin, denselben erzeugendes hybridoma und verfahren fuer die herstellung des gereinigten cytotoxin.
ATE245646T1 (de) Therapeutische nukleoside
DE69429095D1 (de) Humanisierte antikoerper
DK0538754T3 (da) Anvendelse af antistofholdige præparater til immunundertrykkelse
FR2692151B1 (fr) Systeme de traitement du materiau de la zone de transition.
ATE213639T1 (de) Proteinreinigung
IL95494A0 (en) Selective cloning for high monoclonal antibody secreting hybridomas
FI873410A0 (fi) Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita
MX9304731A (es) Polisacaridos de glucogeno.
ES2165506T3 (es) Antagonistas del il-8 para el tratamiento del asma.
DE69111534D1 (de) Verfahren zur Herstellung von Alpha-Olefin durch Ethenolyse.
MX9302629A (es) Purificacion del inhibidor-activador de plasminogeno 2 por cromatografia de inmunoafinidad.
KR950700684A (ko) 시클릭 항-종양 촉진제 화합물, 그의 조성물, 제조 방법 및 용도(Cyclic Anti-Tumor Promoter Compounds, Compositions and Methods for Production and Use)
DE69113750T2 (de) Dimerisierungsverfahren für n-Buten.
ATE66819T1 (de) Antikoerper und antikoerper enthaltende zubereitungen fuer die inhibition von periodontitis.
FR2693228B1 (fr) Structrure écran à gradient de luminosité variable notamment pour tête de tunnel.
DE59105603D1 (de) Monoklonale antikörper gegen den interleukin 2-rezeptor.
AU2629792A (en) Process for the purification of streptolysin 0, intact streptolysin 0 obtained by this process and its use
MX9302112A (es) Separacion selectiva de aflatoxina a partir composiciones que contienen azadiractina.
FR2707464B1 (fr) Perfectionnement aux articles chaussants.
ES536028A0 (es) Un procedimiento para producir interferon inmune humano recombinante intacto